Palo Alto Investors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $121M | Sell |
|
|||||
|
2022
Q2 | $122M | Hold |
|
|||||
|
2022
Q1 | $164M | Sell |
|
|||||
|
2021
Q4 | $186M | Sell |
|
|||||
|
2021
Q3 | $179M | Sell |
|
|||||
|
2021
Q2 | $182M | Buy |
|
|||||
|
2021
Q1 | $183M | Buy |
|
|||||
|
2020
Q4 | $180M | Buy |
|
|||||
|
2020
Q3 | $140M | Buy |
|
|||||
|
2020
Q2 | $119M | Sell |
|
|||||
|
2020
Q1 | $73M | Sell |
|
|||||
|
2019
Q4 | $96.2M | Sell |
|
|||||
|
2019
Q3 | $116M | Sell |
|
|||||
|
2019
Q2 | $184M | Buy |
|
|||||
|
2019
Q1 | $200M | Buy |
|
|||||
|
2018
Q4 | $224M | Sell |
|
|||||
|
2018
Q3 | $319M | Sell |
|
|||||
|
2018
Q2 | $364M | Sell |
|
|||||
|
2018
Q1 | $392M | Sell |
|
|||||
|
2017
Q4 | $297M | Sell |
|
|||||
|
2017
Q3 | $326M | Sell |
|
|||||
|
2017
Q2 | $280M | Buy |
|
|||||
|
2017
Q1 | $241M | Buy |
|
|||||
|
2016
Q4 | $214M | Buy |
|
|||||
|
2016
Q3 | $242M | Sell |
|
|||||
|
2016
Q2 | $226M | Sell |
|
|||||
|
2016
Q1 | $221M | Sell |
|
|||||
|
2015
Q4 | $261M | Buy |
|
|||||
|
2015
Q3 | $262M | Buy |
|
|||||
|
2015
Q2 | $180M | Buy |
|
|||||
|
2015
Q1 | $177M | Buy |
|
|||||
|
2014
Q4 | $93.6M | Buy |
|
|||||
|
2014
Q3 | $60.3M | Buy |
|
|||||
|
2014
Q2 | $55.5M | Buy |
|
|||||
|
2014
Q1 | $57.3M | Sell |
|
|||||
|
2013
Q4 | $71.9M | Buy |
|
|||||
|
2013
Q3 | $50.6M | Buy |
|
|||||
|
2013
Q2 | $50M | Buy |
|